✦ LIBER ✦
5005 ORAL Exploratory Subgroup Analysis of the TAMRAD Phase 2 GINECO Trial Comparing Tamoxifen (TAM) Plus Everolimus (RAD) With TAM Alone in Patients With Hormone-receptor-positive, HER2-negative Metastatic Breast Cancer (mBC) With Prior Exposure to Aromatase Inhibitors (Als): Implication for Research Strategies
✍ Scribed by Bourqier, C.; Ray-Coquard, I.; Provencal, J.; Cropet, C.; Bourcier, A.V.; Delecroix, V.; Reynaud-Bougnoux, A.; Cretin, J.; Bachelot, T.
- Book ID
- 121948998
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 43 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.